Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.

The macrophage contribution to stress erythropoiesis: when less is enough. Blood (2016) 0.76

Immune Regulation of sickle Cell Alloimmunization. ISBT Sci Ser (2016) 0.75

Dendritic cells and the control of immunity. Nature (1998) 56.54

Tolerogenic dendritic cells. Annu Rev Immunol (2001) 13.77

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med (2000) 6.32

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol (2005) 6.05

Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol (2004) 5.78

Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev (2003) 2.52

Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest (2007) 2.47

Characterization of heme as activator of Toll-like receptor 4. J Biol Chem (2007) 2.38

The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood (2000) 2.32

Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood (2012) 2.10

Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood (2013) 2.05

Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood (2005) 1.86

Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest (2007) 1.67

The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol (2009) 1.66

Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J Clin Invest (2013) 1.58

CD83 expression influences CD4+ T cell development in the thymus. Cell (2002) 1.52

Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood (2012) 1.43

Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J Exp Med (2000) 1.42

Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation (2012) 1.40

The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function. Blood (2006) 1.37

Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. Blood (2012) 1.28

Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276. J Immunol (2007) 1.23

Hemolysis-induced lethality involves inflammasome activation by heme. Proc Natl Acad Sci U S A (2014) 1.20

Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J Immunol (2009) 1.19

TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity. Cancer Res (2011) 1.15

Immunoregulatory effects of HO-1: how does it work? Curr Opin Pharmacol (2009) 1.08

Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major. Am J Hematol (2011) 1.07

Crosstalk between T lymphocytes and dendritic cells. Crit Rev Immunol (2012) 1.07

Dendritic cell CD83: a therapeutic target or innocent bystander? Immunol Lett (2007) 1.02

Effects of protoporphyrins on production of nitric oxide and expression of vascular endothelial growth factor in vascular smooth muscle cells and macrophages. Acta Biochim Pol (2003) 0.95

Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res (2015) 0.90

TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization. Haematologica (2015) 0.90

Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease. Blood (2015) 0.90

A novel mutation in CD83 results in the development of a unique population of CD4+ T cells. J Immunol (2004) 0.90

Towards improved therapeutic CORMs: understanding the reactivity of CORM-3 with proteins. Curr Med Chem (2011) 0.88

Fetal fibronectin signaling induces matrix metalloproteases and cyclooxygenase-2 (COX-2) in amnion cells and preterm birth in mice. J Biol Chem (2012) 0.86

Heme oxygenase-1 regulates dendritic cell function through modulation of p38 MAPK-CREB/ATF1 signaling. J Biol Chem (2014) 0.86

Hemin controls T cell polarization in sickle cell alloimmunization. J Immunol (2014) 0.85

Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients. Eur J Immunol (2015) 0.84

Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses. Immunol Invest (2012) 0.84

Partial dysfunction of Treg activation in sickle cell disease. Am J Hematol (2014) 0.83

Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion. Am J Hematol (2015) 0.82

Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells. Mol Cell Biol (2013) 0.82

Role of interleukin-12 in human Th1 response. Chem Immunol (1996) 0.79

Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series. Transfusion (2015) 0.77

Look out heme, Mac is back in town. Blood (2014) 0.76